AI Execution Layer & Platform Powering Life Sciences

Vi helps life sciences organizations reach trial-eligible patients earlier, keep them supported through treatment, and remove the operational friction that slows programs down. Every action is traceable. Every outcome is measured.

The science is ready. The system that delivers it is not. Enrollment runs behind. Sites underdeliver. Patients who would qualify never learn the trial exists. Every month a program slips is a month of exclusivity spent before anyone is treated.

Vi is the AI execution layer for life sciences. It turns clinical, behavioral, and operational data into next best actions: which patients to reach, which sites to prioritize, which HCPs to engage, and when to move.

Results in Biopharma

  0 1 2 3 4 5 6 7   0 1 2 3 4 5 6   %

Faster clinical trial enrollment

  0 1 2 3   0 1 2 3   %

Reduction in enrollment costs

  0 1 2 3 4   0 1 2     %

In script lift

  0 1 2 3 4 5   0 1   %

Trial acceleration vs. baseline

AI built to power life sciences

Data Web

Powerful, privacy-safe network of real-world signals.

Vi Activate

Precise & predictive targeting to activate new patients.

Vi Engage

Predictive & personalized interactions with patients and providers.

Vi Operate

Agentic suite built to drive operational excellence.

Vi Pulse

Command center for LLM-powered data access, actionable insights, and ROI performance.

How life sciences use Vi’s AI solutions

Vi helps life sciences companies scale across trials and commercialization:

Identify high-probability trial participants using real-world signals

Accelerate recruitment timelines with predictive targeting

Segment and prioritize providers based on prescribing behavior

Deliver compliant, omnichannel engagement to the right audience

Monitor launch performance and course-correct in real-time

Surface operational inefficiencies across field, marketing, and access teams

Automate outreach workflows with approval built in, and optimize field force deployment

Unify siloed commercial, clinical, and engagement data

Case Studies

Trial Enrollment Acceleration for Biotech

A clinical-stage biotech struggled with slow trial enrollment and poor match rates. Vi Activate deployed predictive patient-matching models across licensed EHR and claims data, accelerating enrollment and improving trial site performance dramatically.

  0 1 2 3 4 5 6 7   0 1 2 3 4 5 6   %

Faster trial enrollment

  0 1   0 1   0 1 2 3 4 5 6 7   %

More qualified patient matches

  0 1 2 3   x

Reduction in screen failure rates

Driving Script Lift Through Targeted Provider Outreach

A biopharma company entered a competitive disease area with initially strong script volume, but soon faced prescriber erosion as competitor messaging shifted providers behavior. Their reactive strategy, based on claims data, came too late leading to script decline. Vi segmented providers, identified early intent signals, and activated tailored outreachβ€”reversing decline and driving measurable growth with a 19% net script lift.

  0 1   0 1 2 3 4 5 6 7 8 9   %

Net script lift

  0 1   0 1   %

Script lift in Vi Group

  –   0 1 2 3 4 5 6 7 8   %

Script erosion in non-Vi group (Control)

Agentic Market Research for Drug Development

A Fortune 500 biopharma company lacked timely visibility into drug discovery potential, trial recruitment feasibility, and competitor moves, slowing R&D planning. Vi Operate’s Market Research Agent delivered real-time analytics, surveys, and site selection recommendations, reducing reliance on costly manual research and outside consultants. Compared to traditional claims-based clusters, Vi enabled smarter market selection and resource allocation β€” generating faster, deeper insights that cut trial timelines by 9 months, accelerated speed-to-market, and saved an estimated $55M. All powered by Vi’s robust Data Web covering 96% of U.S. households and tens of thousands of historical market studies.

  0 1 2 3 4 5 6 7 8 9   0 1 2 3   %

Reduced cost of insights report from comparable consulting deliverable

  0 1 2 3 4 5 6 7   0 1 2 3 4   %

Reduction in manual review hours

  0 1 2   0 1 2   %

Reduction in manual review hours

Our security commitment

We adhere to and exceed data security standards, using anonymized data sets and rigorous protocols that ensure privacy and safety.

Frequently asked questions

  • What is an AI execution layer in life sciences?

    An AI execution layer sits between the systems a life sciences organization already runs and the actions those systems should trigger. It turns clinical, real-world, and commercial data into a specific next best action, delivered inside existing workflows. Vi is the AI execution layer for healthcare, life sciences, and wellness.

  • How is Vi different from a commercial analytics or audience platform?

    Analytics platforms produce insight and audience platforms supply a list. Vi produces action. Most tools stop at a segment, a score, or a dashboard and leave execution to the team receiving it. Vi carries the prediction through to a triggered, governed, measurable action, then feeds the outcome back to improve the next prediction.

  • Does Vi replace our CRM, next best action engine, or agency partners?

    No. Vi runs alongside the systems and partners already in place. Productized AI models deploy into existing infrastructure without a rip and replace, and Vi stays model agnostic so organizations can use third party models where those perform best. There is no lock in and no migration required to start.

  • What is a next best action in life sciences?

    A next best action is the most valuable step for a specific HCP, patient, or field team at a given moment: which physician to see next, when to shift a message, which patient is stalling between prescription and first fill. Vi predicts it from prescribing activity, clinical indicators, and real-world behavior, then delivers it into the systems those teams already use.

  • What data sources power patient and HCP targeting?

    The Vi Data Web draws on 50+ licensed data sources providing more than 71,000 attributes per household, combined with de-identified enterprise data. Prescribing activity and clinical indicators sit alongside search intent, care-seeking behavior, and proximity to treatment or trial locations, which is how eligible patients become visible outside the clinical record.

  • Is Vi HIPAA compliant?

    Yes. Vi is HIPAA compliant and holds HITRUST, ISO/IEC 27001:2022, ISO/IEC 27701:2019, and SOC 2 Type 2 certifications. The Vi Data Web operates on de-identified data, and enterprise partner data is anonymized before use. Full documentation, including our data processing agreement and subprocessor list, is available at the Vi Trust Center.

  • How does Vi identify patients for clinical trials and approved therapies?

    Vi detects eligibility signals outside the clinical record. Search behavior around symptoms and treatments, care-seeking patterns, mobility, and site proximity surface patients no listing or claims-based audience would reach. The same prediction and orchestration layer serves trial enrollment and commercial patient finding, so one system covers the product lifecycle rather than two disconnected programs.

  • How does Vi support HCP targeting and engagement?

    Vi runs one model across HCP prioritization and engagement rather than separate targeting and outreach tools. It ranks HCPs by predicted likelihood to act, modeling across prescribing activity, clinical indicators, geography, and engagement patterns, then the orchestration layer decides channel, timing, and sequence and delivers next best actions into the systems field teams already use.

  • How does Vi support a product launch?

    Vi shortens the interval between a launch underperforming and someone knowing why. Performance across activation, engagement, and operations surfaces in one view, showing which audiences and channels are producing. The orchestration layer reallocates continuously rather than waiting for a quarterly readout, so course correction happens during the launch.